Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Molecular imaging in drug development.

Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS.

Nat Rev Drug Discov. 2008 Jul;7(7):591-607. doi: 10.1038/nrd2290. Review.

PMID:
18591980
2.

Applications for site-directed molecular imaging agents coupled with drug delivery potential.

Wang H, Chen X.

Expert Opin Drug Deliv. 2009 Jul;6(7):745-68. doi: 10.1517/17425240902889751. Review.

PMID:
19552614
3.

Using imaging biomarkers to accelerate drug development and clinical trials.

Pien HH, Fischman AJ, Thrall JH, Sorensen AG.

Drug Discov Today. 2005 Feb 15;10(4):259-66. Review.

PMID:
15708744
4.

Emerging applications of kinetic biomarkers in preclinical and clinical drug development.

Turner SM, Hellerstein MK.

Curr Opin Drug Discov Devel. 2005 Jan;8(1):115-26. Review.

PMID:
15679179
5.

Chitosan-based systems for molecular imaging.

Agrawal P, Strijkers GJ, Nicolay K.

Adv Drug Deliv Rev. 2010 Jan 31;62(1):42-58. doi: 10.1016/j.addr.2009.09.007. Epub 2009 Oct 25. Review.

PMID:
19861142
6.

Has molecular and cellular imaging enhanced drug discovery and drug development?

Niu G, Chen X.

Drugs R D. 2008;9(6):351-68. doi: 10.2165/0126839-200809060-00002. Review.

PMID:
18989988
7.

Optical imaging in drug discovery and diagnostic applications.

Licha K, Olbrich C.

Adv Drug Deliv Rev. 2005 Jun 15;57(8):1087-108. Review.

PMID:
15908041
8.

Molecular imaging strategies for drug discovery and development.

Gross S, Piwnica-Worms D.

Curr Opin Chem Biol. 2006 Aug;10(4):334-42. Epub 2006 Jul 5. Review.

PMID:
16822702
9.

Multimodality imaging: novel pharmacological applications of reporter systems.

Stell A, Belcredito S, Ramachandran B, Biserni A, Rando G, Ciana P, Maggi A.

Q J Nucl Med Mol Imaging. 2007 Jun;51(2):127-38. Review.

10.

Molecular imaging with bioconjugates in mouse models of cancer.

Mather S.

Bioconjug Chem. 2009 Apr;20(4):631-43. doi: 10.1021/bc800401x. Review.

PMID:
19086866
11.

In vivo optical imaging: preclinical applications and considerations.

Hickson J.

Urol Oncol. 2009 May-Jun;27(3):295-7. doi: 10.1016/j.urolonc.2008.10.030. Review.

PMID:
19414115
12.

Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm.

Massoud TF, Gambhir SS.

Trends Mol Med. 2007 May;13(5):183-91. Epub 2007 Apr 2. Review.

PMID:
17403616
13.

[Consideration on molecular imaging technology as a tool for drug research and development].

Yajima K, Nishimura S.

Yakugaku Zasshi. 2009 Mar;129(3):297-304. Review. Japanese.

14.

[Molecular imaging for drug development].

Watanabe Y.

Brain Nerve. 2007 Mar;59(3):209-14. Review. Japanese.

PMID:
17370646
15.

Noninvasive structural, functional, and molecular imaging in drug development.

Rudin M.

Curr Opin Chem Biol. 2009 Jun;13(3):360-71. doi: 10.1016/j.cbpa.2009.03.025. Epub 2009 May 14. Review.

PMID:
19447067
16.

Molecular imaging to select cancer therapy and evaluate treatment response.

Mankoff DA.

Q J Nucl Med Mol Imaging. 2009 Apr;53(2):181-92. Review.

17.

Targeted imaging: an important biomarker for understanding disease progression in the era of personalized medicine.

Eckelman WC, Reba RC, Kelloff GJ.

Drug Discov Today. 2008 Sep;13(17-18):748-59. doi: 10.1016/j.drudis.2008.05.009. Epub 2008 Jul 24. Review.

PMID:
18617011
18.

Imaging in the cardiovascular and metabolic disease area.

Comley RA, Kallend D.

Drug Discov Today. 2013 Feb;18(3-4):185-92. doi: 10.1016/j.drudis.2012.09.008. Epub 2012 Sep 29. Review.

PMID:
23032726
19.

Molecular imaging: reporter gene imaging.

Serganova I, Mayer-Kukuck P, Huang R, Blasberg R.

Handb Exp Pharmacol. 2008;(185 Pt 2):167-223. doi: 10.1007/978-3-540-77496-9_8. Review.

PMID:
18626603
20.

Supplemental Content

Support Center